Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer
Clinical trial NCT03326102 · COMPLETED
Trial details
- NCT number
- NCT03326102
- Sponsor
- Daehwa Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-06
- Primary completion
- 2022-12-13
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.